Humacyte announces the appointments of three surgeons and
DURHAM, NC, December 31, 2021 (GLOBE NEWSWIRE) - Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing bioengineered human tissues that are universally implantable at scale Commercial, today announced…